Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Gene Therapy in CNS Disorder
1.2 Key Market Segments
1.2.1 Gene Therapy in CNS Disorder Segment by Type
1.2.2 Gene Therapy in CNS Disorder Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Gene Therapy in CNS Disorder Market Overview
2.1 Global Market Overview
2.1.1 Global Gene Therapy in CNS Disorder Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gene Therapy in CNS Disorder Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Gene Therapy in CNS Disorder Market Competitive Landscape
3.1 Global Gene Therapy in CNS Disorder Sales by Manufacturers (2019-2024)
3.2 Global Gene Therapy in CNS Disorder Revenue Market Share by Manufacturers (2019-2024)
3.3 Gene Therapy in CNS Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gene Therapy in CNS Disorder Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gene Therapy in CNS Disorder Sales Sites, Area Served, Product Type
3.6 Gene Therapy in CNS Disorder Market Competitive Situation and Trends
3.6.1 Gene Therapy in CNS Disorder Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gene Therapy in CNS Disorder Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Gene Therapy in CNS Disorder Industry Chain Analysis
4.1 Gene Therapy in CNS Disorder Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Gene Therapy in CNS Disorder Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Gene Therapy in CNS Disorder Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Therapy in CNS Disorder Sales Market Share by Type (2019-2024)
6.3 Global Gene Therapy in CNS Disorder Market Size Market Share by Type (2019-2024)
6.4 Global Gene Therapy in CNS Disorder Price by Type (2019-2024)
7 Gene Therapy in CNS Disorder Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Therapy in CNS Disorder Market Sales by Application (2019-2024)
7.3 Global Gene Therapy in CNS Disorder Market Size (M USD) by Application (2019-2024)
7.4 Global Gene Therapy in CNS Disorder Sales Growth Rate by Application (2019-2024)
8 Gene Therapy in CNS Disorder Market Segmentation by Region
8.1 Global Gene Therapy in CNS Disorder Sales by Region
8.1.1 Global Gene Therapy in CNS Disorder Sales by Region
8.1.2 Global Gene Therapy in CNS Disorder Sales Market Share by Region
8.2 North America
8.2.1 North America Gene Therapy in CNS Disorder Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gene Therapy in CNS Disorder Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gene Therapy in CNS Disorder Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gene Therapy in CNS Disorder Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gene Therapy in CNS Disorder Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Voyager Therapeutics
9.1.1 Voyager Therapeutics Gene Therapy in CNS Disorder Basic Information
9.1.2 Voyager Therapeutics Gene Therapy in CNS Disorder Product Overview
9.1.3 Voyager Therapeutics Gene Therapy in CNS Disorder Product Market Performance
9.1.4 Voyager Therapeutics Business Overview
9.1.5 Voyager Therapeutics Gene Therapy in CNS Disorder SWOT Analysis
9.1.6 Voyager Therapeutics Recent Developments
9.2 Spark Therapeutics
9.2.1 Spark Therapeutics Gene Therapy in CNS Disorder Basic Information
9.2.2 Spark Therapeutics Gene Therapy in CNS Disorder Product Overview
9.2.3 Spark Therapeutics Gene Therapy in CNS Disorder Product Market Performance
9.2.4 Spark Therapeutics Business Overview
9.2.5 Spark Therapeutics Gene Therapy in CNS Disorder SWOT Analysis
9.2.6 Spark Therapeutics Recent Developments
9.3 Novartis AG
9.3.1 Novartis AG Gene Therapy in CNS Disorder Basic Information
9.3.2 Novartis AG Gene Therapy in CNS Disorder Product Overview
9.3.3 Novartis AG Gene Therapy in CNS Disorder Product Market Performance
9.3.4 Novartis AG Gene Therapy in CNS Disorder SWOT Analysis
9.3.5 Novartis AG Business Overview
9.3.6 Novartis AG Recent Developments
9.4 Bluebird Bio Inc.
9.4.1 Bluebird Bio Inc. Gene Therapy in CNS Disorder Basic Information
9.4.2 Bluebird Bio Inc. Gene Therapy in CNS Disorder Product Overview
9.4.3 Bluebird Bio Inc. Gene Therapy in CNS Disorder Product Market Performance
9.4.4 Bluebird Bio Inc. Business Overview
9.4.5 Bluebird Bio Inc. Recent Developments
9.5 Biogen
9.5.1 Biogen Gene Therapy in CNS Disorder Basic Information
9.5.2 Biogen Gene Therapy in CNS Disorder Product Overview
9.5.3 Biogen Gene Therapy in CNS Disorder Product Market Performance
9.5.4 Biogen Business Overview
9.5.5 Biogen Recent Developments
10 Gene Therapy in CNS Disorder Market Forecast by Region
10.1 Global Gene Therapy in CNS Disorder Market Size Forecast
10.2 Global Gene Therapy in CNS Disorder Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gene Therapy in CNS Disorder Market Size Forecast by Country
10.2.3 Asia Pacific Gene Therapy in CNS Disorder Market Size Forecast by Region
10.2.4 South America Gene Therapy in CNS Disorder Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gene Therapy in CNS Disorder by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Gene Therapy in CNS Disorder Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gene Therapy in CNS Disorder by Type (2025-2030)
11.1.2 Global Gene Therapy in CNS Disorder Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gene Therapy in CNS Disorder by Type (2025-2030)
11.2 Global Gene Therapy in CNS Disorder Market Forecast by Application (2025-2030)
11.2.1 Global Gene Therapy in CNS Disorder Sales (Kilotons) Forecast by Application
11.2.2 Global Gene Therapy in CNS Disorder Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
